These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23644971)

  • 21. [Prevalence of resistance to antimicrobial agents of H. pylori].
    Raymond J; Kalach N; Lamarque D; Burucoa C
    Arch Pediatr; 2010 Jun; 17(6):816-7. PubMed ID: 20654908
    [No Abstract]   [Full Text] [Related]  

  • 22. "Modern therapies for Helicobacter pylori infection".
    Go MF
    Acta Gastroenterol Latinoam; 1996; 26(2):119-23. PubMed ID: 9137668
    [No Abstract]   [Full Text] [Related]  

  • 23. [Alternative schemes of eradication therapy and ways of overcoming acquired resistance of Helicobacter pylori to the treatment].
    Tsimmerman IaS
    Klin Med (Mosk); 2004; 82(2):9-15. PubMed ID: 15106503
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of probiotics in Helicobacter pylori eradication therapy.
    Medeiros JA; Pereira MI
    J Clin Gastroenterol; 2013 Jan; 47(1):1-5. PubMed ID: 23222208
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of Helicobacter pylori infection in adults].
    Boixeda D
    Enferm Infecc Microbiol Clin; 1994 May; 12 Suppl 1():41-7. PubMed ID: 8054370
    [No Abstract]   [Full Text] [Related]  

  • 26. Antibiotic therapy for Helicobacter pylori.
    Collins J; Ali-Ibrahim A; Smoot DT
    Med Clin North Am; 2006 Nov; 90(6):1125-40. PubMed ID: 17116440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and safety of repeated quadruple therapy in Helicobacter pylori infection after failure of second-line quadruple therapy: repeated quadruple therapy as a third-line therapy.
    Lee SK; Lee SW; Park JY; Kwon BS; Kim SY; Hyun JJ; Kim JH; Jung SW; Koo JS; Yim HJ; Choi JH
    Helicobacter; 2011 Oct; 16(5):410-4. PubMed ID: 21923688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review article: rifabutin in the treatment of refractory Helicobacter pylori infection.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2012 Jan; 35(2):209-21. PubMed ID: 22129228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial.
    Cammarota G; Branca G; Ardito F; Sanguinetti M; Ianiro G; Cianci R; Torelli R; Masala G; Gasbarrini A; Fadda G; Landolfi R; Gasbarrini G
    Clin Gastroenterol Hepatol; 2010 Sep; 8(9):817-820.e3. PubMed ID: 20478402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Resistance of Helicobacter pylori to clarithomycin].
    Petersen AM; Schradieck W; Krogfelt KA
    Ugeskr Laeger; 1998 Jun; 160(23):3412-3. PubMed ID: 9627511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Helicobacter pylori infection.
    O'Connor A; Gisbert J; O'Morain C
    Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate.
    Yoon H; Kim N; Lee BH; Hwang TJ; Lee DH; Park YS; Nam RH; Jung HC; Song IS
    Helicobacter; 2009 Oct; 14(5):77-85. PubMed ID: 19751431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibility testing for Helicobacter pylori: implications for clinical practice.
    Shmuely H; Niv Y
    Isr Med Assoc J; 2001 Apr; 3(4):266-8. PubMed ID: 11344839
    [No Abstract]   [Full Text] [Related]  

  • 34. Getting to the route of Helicobacter pylori treatment.
    Goddard AF
    J Antimicrob Chemother; 1998 Jul; 42(1):1-3. PubMed ID: 9700523
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of Helicobacter pylori infection 2012.
    Tepes B; O'Connor A; Gisbert JP; O'Morain C
    Helicobacter; 2012 Sep; 17 Suppl 1():36-42. PubMed ID: 22958154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Helicobacter pylori infection.
    Cavallaro LG; Egan B; O'Morain C; Di Mario F
    Helicobacter; 2006 Oct; 11 Suppl 1():36-9. PubMed ID: 16925610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The actions of bismuth in the treatment of Helicobacter pylori infections: an update.
    Ge R; Chen Z; Zhou Q
    Metallomics; 2012 Mar; 4(3):239-43. PubMed ID: 22358069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Is gastric acid secretion inhibition necessary for successful eradication of Helicobacter pylori?].
    Müller P; Simon B
    Fortschr Med; 1996 Aug; 114(22-23):275-6. PubMed ID: 8974962
    [No Abstract]   [Full Text] [Related]  

  • 39. Change in antibiotic resistance of Helicobacter pylori strains and the effect of A2143G point mutation of 23S rRNA on the eradication of H. pylori in a single center of Korea.
    Hwang TJ; Kim N; Kim HB; Lee BH; Nam RH; Park JH; Lee MK; Park YS; Lee DH; Jung HC; Song IS
    J Clin Gastroenterol; 2010 Sep; 44(8):536-43. PubMed ID: 20179610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Helicobacter pylori infection: what to do after first intent treatment failure?].
    Delchier JC
    Rev Prat; 2008 Sep; 58(13):1442-4. PubMed ID: 18924328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.